PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PanGenomic Health Inc. has announced an expected resolution to its management cease trade order by filing overdue 2023 annual financial documents by June 28, 2024, following payment of its outstanding auditor invoices. The delay in annual filings also caused a postponement in the company’s interim financial reports, which are now anticipated to be filed shortly after the annual ones. While company executives face trading restrictions until filings are complete and the order is lifted, shareholders remain free to trade.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.
